Ampio Pharmaceuticals Inc (AMPE)
0.0022
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Ampio Pharmaceuticals Total Liabilities (Quarterly): 2.376M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.376M |
September 30, 2023 | 2.271M |
June 30, 2023 | 2.589M |
March 31, 2023 | 2.857M |
December 31, 2022 | 1.799M |
September 30, 2022 | 4.989M |
June 30, 2022 | 7.118M |
March 31, 2022 | 10.53M |
December 31, 2021 | 11.54M |
September 30, 2021 | 5.199M |
June 30, 2021 | 6.348M |
March 31, 2021 | 4.949M |
December 31, 2020 | 5.366M |
September 30, 2020 | 4.819M |
June 30, 2020 | 5.518M |
March 31, 2020 | 6.854M |
December 31, 2019 | 7.558M |
September 30, 2019 | 11.83M |
June 30, 2019 | 9.778M |
March 31, 2019 | 13.06M |
December 31, 2018 | 8.794M |
September 30, 2018 | 13.34M |
June 30, 2018 | 15.44M |
March 31, 2018 | 23.52M |
December 31, 2017 | 49.49M |
Date | Value |
---|---|
September 30, 2017 | 9.586M |
June 30, 2017 | 9.331M |
March 31, 2017 | 5.818M |
December 31, 2016 | 6.962M |
September 30, 2016 | 7.051M |
June 30, 2016 | 3.222M |
March 31, 2016 | 3.932M |
December 31, 2015 | 12.49M |
September 30, 2015 | 10.61M |
June 30, 2015 | 4.608M |
March 31, 2015 | 3.306M |
December 31, 2014 | 4.810M |
September 30, 2014 | 4.270M |
June 30, 2014 | 5.072M |
March 31, 2014 | 5.391M |
December 31, 2013 | 2.804M |
September 30, 2013 | 2.429M |
June 30, 2013 | 2.787M |
March 31, 2013 | 2.091M |
December 31, 2012 | 2.017M |
September 30, 2012 | 1.691M |
June 30, 2012 | 1.502M |
March 31, 2012 | 1.329M |
December 31, 2011 | 1.723M |
September 30, 2011 | 2.135M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.799M
Minimum
Dec 2022
11.54M
Maximum
Dec 2021
5.452M
Average
5.199M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
FluoroPharma Medical Inc | 10.51M |
Evolutionary Genomics Inc | 7.946M |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | 2.406M |
Regenerx Biopharmaceuticals Inc | 3.931M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.736M |
Shareholders Equity (Quarterly) | 3.36M |